|
1
|
Ikonomidou C, Bosch F, Miksa M, Bittigau
P, Vöckler J, Dikranian K, Tenkova TI, Stefovska V, Turski L and
Olney JW: Blockade of NMDA receptors and apoptotic
neurodegeneration in the developing brain. Science. 283:70–74.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ikonomidou C, Bittigau P, Ishimaru MJ,
Wozniak DF, Koch C, Genz K, Price MT, Stefovska V, Hörster F,
Tenkova T, et al: Ethanol-induced apoptotic neurodegeneration and
fetal alcohol syndrome. Science. 287:1056–1060. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Jevtovic-Todorovic V, Hartman RE, Izumi Y,
Benshoff ND, Dikranian K, Zorumski CF, Olney JW and Wozniak DF:
Early exposure to common anesthetic agents causes widespread
neurodegeneration in the developing rat brain and persistent
learning deficits. J Neurosci. 23:876–882. 2003.PubMed/NCBI
|
|
4
|
Dobbing J and Sands J: Comparative aspects
of the brain growth spurt. Early Hum Dev. 3:79–83. 1979. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Felderhoff-Mueser U and Ikonomidou C:
Mechanisms of neurodegeneration after paediatric brain injury. Curr
Opin Neurol. 13:141–145. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Fredriksson A, Pontén E, Gordh T and
Eriksson P: Neonatal exposure to a combination of
N-methyl-D-aspartate and gamma-aminobutyric acid type A receptor
anesthetic agents potentiates apoptotic neurodegeneration and
persistent behavioral deficits. Anesthesiology. 107:427–436. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wilder RT, Flick RP, Sprung J, Katusic SK,
Barbaresi WJ, Mickelson C, Gleich SJ, Schroeder DR, Weaver AL and
Warner DO: Early exposure to anesthesia and learning disabilities
in a population-based birth cohort. Anesthesiology. 110:796–804.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Servick K: Biomedical Research.
Researchers struggle to gauge risks of childhood anesthesia.
Science. 346:1161–1162. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Olney JW, Ishimaru MJ, Bittigau P and
Ikonomidou C: Ethanol-induced apoptotic neurodegeneration in the
developing brain. Apoptosis. 5:515–521. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Renault TT, Floros KV, Elkholi R, Corrigan
KA, Kushnareva Y, Wieder SY, Lindtner C, Serasinghe MN, Asciolla
JJ, Buettner C, et al: Mitochondrial shape governs BAX-induced
membrane permeabilization and apoptosis. Mol Cell. 57:69–82. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yin H and Zhu M: Free radical oxidation of
cardiolipin: Chemical mechanisms, detection and implication in
apoptosis, mitochondrial dysfunction and human diseases. Free Radic
Res. 46:959–974. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Jawaid P, ur Rehman M, Yoshihisa Y, Li P,
Zhao Ql, Hassan MA, Miyamoto Y, Shimizu T and Kondo T: Effects of
SOD/catalase mimetic platinum nanoparticles on radiation-induced
apoptosis in human lymphoma U937 cells. Apoptosis. 19:1006–1016.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li M, Wang W, Xue J, Gu Y and Lin S:
Meta-analysis of the clinical value of Astragalus membranaceus in
diabetic nephropathy. J Ethnopharmacol. 133:412–419. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Matkovic Z, Zivkovic V, Korica M, Plavec
D, Pecanic S and Tudoric N: Efficacy and safety of Astragalus
membranaceus in the treatment of patients with seasonal allergic
rhinitis. Phytother Res. 24:175–181. 2010.PubMed/NCBI
|
|
15
|
Qu YZ, Li M, Zhao YL, Zhao ZW, Wei XY, Liu
JP, Gao L and Gao GD: Astragaloside IV attenuates cerebral
ischemia-reperfusion-induced increase in permeability of the
blood-brain barrier in rats. Eur J Pharmacol. 606:137–141. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li M, Ma RN, Li LH, Qu YZ and Gao GD:
Astragaloside IV reduces cerebral edema post-ischemia/reperfusion
correlating the suppression of MMP-9 and AQP4. Eur J Pharmacol.
715:189–195. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
He Y, Du M, Gao Y, Liu H, Wang H, Wu X and
Wang Z: Astragaloside IV attenuates experimental autoimmune
encephalomyelitis of mice by counteracting oxidative stress at
multiple levels. PLoS One. 8:e764952013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gui D, Huang J, Guo Y, Chen J, Chen Y,
Xiao W, Liu X and Wang N: Astragaloside IV ameliorates renal injury
in streptozotocin-induced diabetic rats through inhibiting
NF-κB-mediated inflammatory genes expression. Cytokine. 61:970–977.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ding Y, Yuan S, Liu X, Mao P, Zhao C,
Huang Q, Zhang R, Fang Y, Song Q, Yuan D, et al: Protective effects
of astragaloside IV on db/db mice with diabetic retinopathy. PLoS
One. 9:e1122072014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Xu W, Shao X, Tian L, Gu L, Zhang M, Wang
Q, Wu B, Wang L, Yao J, Xu X, et al: Astragaloside IV ameliorates
renal fibrosis via the inhibition of mitogen-activated protein
kinases and antiapoptosis in vivo and in vitro. J Pharmacol Exp
Ther. 350:552–562. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhang ZG, Wu L, Wang JL, Yang JD, Zhang J,
Zhang J, Li LH, Xia Y, Yao LB, Qin HZ and Gao GD: Astragaloside IV
prevents MPP+-induced SH-SY5Y cell death via the
inhibition of Bax-mediated pathways and ROS production. Mol Cell
Biochem. 364:209–216. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sun Q, Jia N, Wang W, Jin H, Xu J and Hu
H: Protective effects of astragaloside IV against amyloid beta1-42
neurotoxicity by inhibiting the mitochondrial permeability
transition pore opening. PLoS One. 9:e988662014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Miloso M, Scuteri A, Foudah D and Tredici
G: MAPKs as mediators of cell fate determination: An approach to
neurodegenerative diseases. Curr Med Chem. 15:538–548. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Friedlander RM: Apoptosis and caspases in
neurodegenerative diseases. N Engl J Med. 348:1365–1375. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yang H, Liang G, Hawkins BJ, Madesh M,
Pierwola A and Wei H: Inhalational anesthetics induce cell damage
by disruption of intracellular calcium homeostasis with different
potencies. Anesthesiology. 109:243–250. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Blaylock M, Engelhardt T and Bissonnette
B: Fundamentals of neuronal apoptosis relevant to pediatric
anesthesia. Paediatr Anaesth. 20:383–395. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Skowrońska M and Albrecht J: Oxidative and
nitrosative stress in ammonia neurotoxicity. Neurochem Int.
62:731–737. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Karin M and Lin A: NF-kappaB at the
crossroads of life and death. Nat Immunol. 3:221–227. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Mincheva-Tasheva S and Soler RM: NF-κB
signaling pathways: Role in nervous system physiology and
pathology. Neuroscientist. 19:175–194. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Sanders RD, Sun P, Patel S, Li M, Maze M
and Ma D: Dexmedetomidine provides cortical neuroprotection: Impact
on anaesthetic-induced neuroapoptosis in the rat developing brain.
Acta Anaesthesiol Scand. 54:710–716. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Shao A, Guo S, Tu S, Ammar AB, Tang J,
Hong Y, Wu H and Zhang J: Astragaloside IV alleviates early brain
injury following experimental subarachnoid hemorrhage in rats. Int
J Med Sci. 11:1073–1081. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Luo Y, Qin Z, Hong Z, Zhang X, Ding D, Fu
JH, Zhang WD and Chen J: Astragaloside IV protects against ischemic
brain injury in a murine model of transient focal ischemia.
Neurosci Lett. 363:218–223. 2004. View Article : Google Scholar : PubMed/NCBI
|
